Abstract
The effects of methylazoxymethanol (MAM)-induced brain lesions on vacuous chewing movements (VCM) were examined in rats given chronic haloperidol treatment (0.1 or 1 mg/kg/day) for 18 months. At the end of the experiment striatal, pallidal, and nigral activities of glutamate decarboxylase (GAD) were measured. MAM-lesioned rats had an elevated rate of VCMs compared to unlesioned controls. This effect was stable during the whole 18-month experiment. In unlesioned control rats chronic haloperidol produced a gradual increase in VCM rates, but this effect was not further exacerbated in MAM-lesioned animals. After chronic haloperidol treatment with the higher dose (1 mg/kg/day) GAD activity was reduced in substantia nigra (-20%), globus pallidus (-35%), and striatum (-26%) of unlesioned rats. MAM caused a reduction of GAD activity in substantia nigra (-29%) and globus pallidus (-29%). Chronic haloperidol did not influence these effects of MAM-induced lesion. The present results show that a MAM-induced brain lesion, in contrast to cortical ablations, cannot be used to amplify the haloperidol-induced VCM increase or influence the nigral GAD activity in a rat model for tardive dyskinesia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Balduini W, Abbracchio MP, Lombardelli G, Cattabeni F (1984) Loss of intrinsic striatal neurons after methylazoxymethanol acetate in pregnant rats. Dev Brain Res 15:133–136
Beaulieu M, Coyle JT (1981) Effects of fetal methylazoxymethanol acetate lesion on the synaptic neurochemistry of the adult rat striatum. J Neurochem 37:878–887
Fibiger HC, Nagy JI, Staines WA, Vincent SR (1980) Organization and plasticity of GABAergic neurons in some extrapyramidal nuclei of the rat. Brain Res Bull 5:131–135
Glassman RB, Glassman HN (1980) Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology 69:19–25
Gunne LM, Hägström J-E (1983) Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology 81:191–194
Gunne LM, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77:134–139
Gunne LM, Häggström J-E, Sjöquist B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309:347–349
Gunne LM, Bachus SE, Gale K (1988a) Oral movements induced by interference with nigral GABA neurotransmission: relationship to tardive dyskinesias. Exp Neurol 100:459–469
Gunne LM, Häggström J-E, Johansson P, Levin ED, Terenius L (1988b) Neurobiochemical changes in tardive dyskinesia. L'Encéphale XIV:167–173
Hallman H, Jonsson G (1984) Monoamine neurotransmitter metabolism in microencephalic rat brain after prenatal methylazoxymethanol treatment. Brain Res Bull 13:383–389
Jeste DV, Wyatt RJ (1987) Aging and tardive dyskinesia. In: Miller NE, Cohen GD (eds) Schizophrenia and aging. Guilford Press, New York, pp 275–286
Johansson P, Bondesson U, Gunne LM (1988) Long-term effects of melperone on oral movements in rats. In: Steinhagen-Thiessen E, Knook DL (eds) Trends in biomedical gerontology, vol 1. TNO Institute for Experimental Gerontology, Rijswijk, pp 263–272
Johnston MV, Coyle JT (1979) Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res 170:135–155
Johnston MV, Coyle JT (1980) Ontgeny of neurochemical markers for noradrenergic, GABAergic, and cholinergic neurons in neocortex lesioned with methylazoxymethanol acetate. J Neurochem 34:1429–1441
Jonsson G, Hallman H (1982) Effects of prenatal methylazoxymethanol treatment on the development of central monoamine neurons. Dev Brain Res 2:513–530
Lloyd KG, Hornykiewicz O (1977) Effect of chronic neuroleptic orL-dopa administration on GABA levels in the rat substantia nigra. Life Sci 21:1489–1496
Mithani S, Atmadja S, Baimbridge KG, Fibiger HC (1987) Neuroleptic induced oral dyskinesias: effect of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology 93:94–100
Pellegrino LJ, Pellegrino AS, Cushman AJ (1981) A stereotaxic atlas of the rat brain, 2nd edn. Plenum Press, New York
Rupniak NMJ, Prestwich SA, Horton RW, Jenner P, Marsden CD (1987) Alterations in cerebral glutamic acid decarboxylase and3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine. J Neural Transm 68:113–125
Sant WW, Ellison G (1984) Drug holidays alter onset of oral movements in rats following chronic haloperidol. Biol Psychiatry 19:95–99
Scatton B, Worms P, Lloyd KG, Bartholini G (1982) Cortical modulation of striatal function. Brain Res 232:331–343
Segovia J, Garcia-Munoz M (1987) Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation. Neuropharmacology 26:1449–1451
Spatz M, Laquer GL (1968) Transplacental chemical induction of microencephaly in two strains of rats. Proc Soc Exp Biol Med 129:705–710
Vernier P, Julien J-F, Rataboul P, Fourrier O, Feuerstein C, Mallet J (1988) Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. J Neurochem 51:1375–1380
Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530–532
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johansson, P. Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats. Psychopharmacology 100, 72–76 (1990). https://doi.org/10.1007/BF02245793
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245793